IMMX
Immix Biopharma Inc

4,479
Mkt Cap
$427.93M
Volume
3.00
52W High
$8.97
52W Low
$1.34
PE Ratio
-10.27
IMMX Fundamentals
Price
$8.07
Prev Close
$8.49
Open
$8.50
50D MA
$6.10
Beta
1.26
Avg. Volume
1.01M
EPS (Annual)
-$0.7641
P/B
32.26
Rev/Employee
$0.00
$45.62
Loading...
Loading...
News
all
press releases
Short Interest in Immix Biopharma, Inc. (NASDAQ:IMMX) Rises By 31.9%
Immix Biopharma, Inc. (NASDAQ:IMMX - Get Free Report) was the recipient of a significant growth in short interest during the month of January. As of January 30th, there was short interest totaling...
MarketBeat·14d ago
News Placeholder
More News
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Stock Rating Lowered by Wall Street Zen
Wall Street Zen cut Immix Biopharma from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·16d ago
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Rating Increased to Hold at Wall Street Zen
Wall Street Zen raised Immix Biopharma from a "sell" rating to a "hold" rating in a research report on Saturday...
MarketBeat·1mo ago
News Placeholder
Immix Biopharma (IMMX) Shares Slip As Investors Focus On Plans To Offer And Sell $750 Million In Securities
Immix Biopharma Inc (NASDAQ: IMMX) shares are trading lower Monday after the company filed a new shelf registration statement.read more...
Benzinga·2mo ago
News Placeholder
Immix Biopharma, Inc. (NASDAQ:IMMX) Short Interest Up 27.5% in December
Immix Biopharma, Inc. (NASDAQ:IMMX - Get Free Report) was the target of a large growth in short interest in the month of December. As of December 15th, there was short interest totaling 1,746,822...
MarketBeat·2mo ago
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen upgraded Immix Biopharma from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·3mo ago
News Placeholder
FY2025 EPS Estimates for Immix Biopharma Lifted by Analyst
Immix Biopharma, Inc. (NASDAQ:IMMX - Free Report) - Equities research analysts at HC Wainwright increased their FY2025 earnings estimates for Immix Biopharma in a research report issued on Tuesday...
MarketBeat·3mo ago
News Placeholder
Nasdaq, S&P 500 Futures Rise Ahead Of Fed Decision This Week: Why NFLX, CFLT, BA, LLY, IMMX Are On Traders' Radar
Market-based odds now show an 87% chance of a rate cut.
Stocktwits·3mo ago
News Placeholder
Immix Biopharma (NASDAQ:IMMX) Trading 4.5% Higher - What's Next?
Immix Biopharma (NASDAQ:IMMX) Shares Up 4.5% - What's Next...
MarketBeat·3mo ago
News Placeholder
HC Wainwright Reduces Earnings Estimates for Immix Biopharma
Immix Biopharma, Inc. (NASDAQ:IMMX - Free Report) - Research analysts at HC Wainwright cut their FY2025 earnings per share (EPS) estimates for shares of Immix Biopharma in a research report issued on...
MarketBeat·4mo ago
<
1
2
...
>

Latest IMMX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.